Novel FGF21 analogues through structure-based optimization for therapeutic development
Yiqing Guo, Yuxuan Bao, Zhichao Chen, Zhiheng Rao, Yongde Luo, Sheng Ye, Si Liu · 2024
Read Novel FGF21 analogues through structure-based optimization for therapeutic development by Yiqing Guo, Yuxuan Bao, Zhichao Chen, Zhiheng Rao, Yongde Luo, Sheng Ye, Si Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12040742.txt.
Description
Yiqing Guo and six co-authors describe their work on new forms of FGF21, a protein that helps the body manage energy and sugar. Drugs based on it could treat obesity and related illness, but the natural form fades fast in the body and works too weakly. The team compared protein sequences to find the spots where small changes might make it stronger and last longer.
They built two changed forms and fused each one to a long-lived protein part used in many drugs. Both forms showed much stronger action in their tests than the base protein. The authors argue that these designs are good candidates for further study as treatments for weight and blood sugar problems. The paper sets out how the forms were found, made, and checked, so other teams can build on the same plan.
Catalog record
| CREATOR | Yiqing Guo, Yuxuan Bao, Zhichao Chen, Zhiheng Rao, Yongde Luo, Sheng Ye, Si Liu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |